Introduction: Reservation of pedipacks (50 ml filtered red cell concentrate with additive solution SAGM) out of 1 donor can reduce donorexposition. This prospective efficacy study analyses the benefits, release and expiry of these pedipacks (PP) in high risk newborns (HRN).
Methods: 45 HRN, 28.5 wks ±2.5; 1095g ±400g, were selected for a serie PP out of 1 donor. Inclusioncriteria: estimated time of admission > 21 days, and increased need for transfusion due to cardiorespiratory instability or frequent bloodsamples. Control group: 54 low risk prematures (LRN), 30.4wks ± 1.5; 1315 g ± 330, no inclusioncriteria. To prevent expiry after 35 days, the PP (3-4/serie) were released for general use after 21 days.
Results: Out of 50 series (195 PP) for 45 HRN 3 series were given to 2/45 HRN, 2 series to 1/45 and 1 serie to 42/45 HRN. Mean transfusion rate was 3.1 PP in the HRN, and 0.4 in the LRN. In the LRN 35/54 were not transfused, 19/54 received 1-2 PP. In both groups transfused newborns were exposed to 1.1 donor in average. From 50 series PP 140/195 (72%) were used<21 days, another 25/195 (13%) < 35 days. 30/195 (15%) expired, mainly because of logistic problems in the introductionfase.
Conclusion: In terms of efficacy reservation of PP from one donor for HRN results in a considerable reduction of donorexposition, is possible on clinical parameters and can be optimized by simple administrative measures.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Vries, C., De Wildt-Eggen, J., Schepers, W. et al. Evaluation of reservation of serie pedipacks from a single donor for high risk premature newborns. 78. Pediatr Res 42, 398 (1997). https://doi.org/10.1203/00006450-199709000-00098
Issue Date:
DOI: https://doi.org/10.1203/00006450-199709000-00098